NCT03880292

Brief Summary

A multicenter, international prospectively collected patient cohort undergoing high-risk spinal cord level surgery or spinal osteotomy procedures will be enrolled to establish the incidence of intraoperative alerts in high-risk spinal cord cases, and explore factors associated with mitigating injury. Baseline, intraoperative, and postoperative characteristics, including demographics, radiological features, lower extremity motor score (LEMS), procedure, anesthetic agents used, and baseline blood pressure will be recorded for either adult patients or pediatric patients.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
569

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
14 countries

24 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 19, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

November 21, 2022

Status Verified

November 1, 2022

Enrollment Period

2.9 years

First QC Date

March 13, 2019

Last Update Submit

November 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of intraoperative neuromontoring alerts

    Number of intraoperative neuromonitoring alert, defined as a major change in neuromonitoring signals: * SSEP: amplitude loss \> 50% * MEP: amplitude loss \> 50% in two of three muscle groups and/or * EMG: sustained activity for \> 10 seconds

    Intraoperative

Secondary Outcomes (4)

  • Intraoperative monitoring alert

    Intraoperative

  • Success rate of reversal maneuvers to restore signal above the threshold

    Intraoperative

  • Neurological status

    Baseline up to 30 days postoperative

  • Timing of intraoperative monitoring alerts

    Intraoperative

Study Arms (1)

Intraoperative Maneuvers

OTHER

To document intraoperative maneuvers performed in repsonse to alerts

Procedure: Document intraoperative Maneuvers

Interventions

Monitoring procedure during surgery

Intraoperative Maneuvers

Eligibility Criteria

Age10 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>10 years to \<80 years
  • Neurologically intact spinal cord (with or without radiculopathy)
  • Undergoing primary or revision procedure in the spine
  • Anterior and/or posterior surgical approach for any of the following:
  • Correction of spinal deformity with a major Cobb angle of ≥ 80° in the coronal or sagittal plane
  • Correction of high grade spondylolisthesis (Grades 3- 5)
  • Posterior column or 3-column osteotomy
  • Requiring multimodal neuromonitoring with EMG, SSEP, and MEP as per standard of care
  • Informed consent obtained for patients i.e.:
  • Ability to understand the content of the patient information
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated EC/IRB approved written informed consent OR
  • Written consent obtained according to defined and IRB/EC approved procedures for patients who are not able to provide independent written informed consent

You may not qualify if:

  • Upper motor neuron lesion
  • Growing rods or growth guidance procedures
  • Tether or staple procedures
  • Stand-alone cervical deformity correction procedures
  • Any not medically managed severe systemic disease
  • Recent history of substance abuse (ie recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the study period
  • Prisoner
  • Participation in any other medical device or medicinal product study that could influence the results of the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

UC San Franciisco

San Francisco, California, 94143, United States

Location

University of Minnesota

Minneapolis, Minnesota, 55454, United States

Location

Columbia University Medical Center

New York, New York, 10032, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

University of Virginia

Charlottesville, Virginia, 22904, United States

Location

Royal North Shore Hospital

Saint Leonards, 2065, Australia

Location

Hospital Infantil Joana de Gusmão

Florianópolis, 88025, Brazil

Location

Hospital das clinicas de São Paulo e AACD

São Paulo, Brazil

Location

Shriners Hospital for Children

Montreal, 124001, Canada

Location

Montreal General Hospital

Montreal, Canada

Location

Toronto Western Hospital

Toronto, M5T 2S8, Canada

Location

Nanjing Drum Tower Hospital

Nanjing, 210008, China

Location

Queen Mary Hospital

Hong Kong, Hong Kong

Location

Mallika Spine Centre

Guntur, 522001, India

Location

Kothari Medical Centre

Kolkata, 700027, India

Location

Tel Aviv Medical Center - Dana Children's Hospital

Tel Aviv, Israel

Location

Hamamatsu University School of Medicine

Hamamatsu, Japan

Location

University Medical Center St. Radboud

Nijmegen, Netherlands

Location

Ghurki Trust Teaching Hospital

Lahore, Pakistan

Location

Hospital Vall d'Helbron

Barcelona, 08035, Spain

Location

Acibadem Maslak Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

Guys Hospital

London, United Kingdom

Location

Salford Royal Hospital

Manchester, United Kingdom

Location

Nottingham Queens Medical Centre

Nottingham, NG7 2UH, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2019

First Posted

March 19, 2019

Study Start

May 15, 2019

Primary Completion

March 31, 2022

Study Completion

November 1, 2022

Last Updated

November 21, 2022

Record last verified: 2022-11

Locations